获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Marshall Wace North America LP

七月 2026

  • Home
  • Marshall Wace North America LP

七月 2026的Marshall Wace North Amer...市场份额分析

Quantitative research programme at Marshall Wace. Alpha research, signal generation, backtesting, and systematic strategy development for PhD and Master’s graduates at a leading hedge fund in London.
成立年份1997
员工501 - 1000
年营收$500M - $1B
mwam.com
Marshall Wace North America LP
Marshall Wace North America LP(包含公司地区分支机构)
  • mwam.com
    mwam.com
查看更多网站流量和参与度信息

Marshall Wace North America LP收入截至 七月 2026为 500M - 1B

Marshall Wace North America LP主要域名产生的收入

3 年中Marshall Wace North America LP主要域名的收入

Marshall Wace North America LP主要域名的收入


Marshall Wace North America LP热门域名的总访问量

了解Marshall Wace North America LP市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Marshall Wace North America LP热门域名的平均访问时长

分析Marshall Wace North America LP参与度指标。

过去 3 个月的平均访问时长

子公司明细

Marshall Wace North America LP热门域名的平均页面浏览量

了解Marshall Wace North America LP如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Marshall Wace North America LP 采用的主要技术

这些是排名前 Marshall Wace North America LP 的顶级域名所使用的网站技术(按行业分列)

转化和分析 (5)

Google Analytics

Google Analytics

付款和货币 (5)

营销 (3)

Google Marketing Platform

Google Marketing Platform

人才招聘 (3)

Greenhouse

Greenhouse

更多技术

11

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Marshall Wace North America LP 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Marshall Wace LLP hires Dan Schatz as head of credit.Adding to the problems, when MW hired Dan Schatz from Citadel to be the head of credit, Citadel got very angry and lawyered up.
新闻Marshall Wace LLP invested into Draig Therapeutics Ltd $65M in Series B on Jul 13th '26.Also this week, Welsh biotech Draig Therapeutics completed a Series B, raising $65 million in funding led by Deep Track Capital - with participation from Janus Henderson Investors, Marshall Wace, British Business Bank and Jefferson Life Sciences - that will be used to develop its therapies for neuropsychiatric disorders.
新闻Marshall Wace LLP invested into Ray Therapeutics, Inc. in Series B on Apr 21st '26.Ray's Series B, announced 21 April, was led by Janus Henderson Investors, joined by new investors Adage Capital Management, Franklin Templeton, Invus and Marshall Wace, alongside existing backers 4BIO Capital, Deerfield, MRL Ventures Fund, Norwest, Novo Holdings and Platanus.

查看 Marshall Wace North America LP 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。